This weekend, Stephen Hahn, the commissioner of the U.S. Food and Drug Administration, attracted criticism when he substantially overstated the benefits of an experimental Covid-19 therapy. At a press conference with Trump, Hahn said that a treatment using blood plasma from recovered patients could save 35 of every 100 people who would have died. Those high-profile remarks were incorrect, and they were repeated by others in the Trump administration. Hahn late Monday clarified some of what the data on blood plasma actually show.
But the episode has raised questions about how the agency will review a vaccine, as well as its scientific independence. Senior Editor for Health Care Drew Armstrong spoke to Hahn about the agency’s role in an increasingly politicized federal virus response.
See omnystudio.com/listener for privacy information.
Introducing: Bloomberg News Now
Introducing: Elon, Inc.
Covid Cures and Conspiracies Introducing: The Deadly Cure
Introducing: Crash Course
Targeting the Toughest Diseases (Sponsored Content)
Episode Seven: Gut Instinct
Episode Six: The Truth About Health and Weight
Episode Five: Just Don’t Call it A Diet
Episode Four: A Weight-Loss Mecca’s Secrets
Episode Three: How to Launch a Diet Empire
Episode Two: Once Upon a Diet
Episode One: When a Calorie Isn’t A Calorie
Introducing: Losing It
We've Been Nominated for a Webby!
Breakthrough, Part Nine: The Next Pandemic
Breakthrough, Part Eight: The Future of mRNA
Breakthrough, Part Seven: The Vaccine Race
Breakthrough, Part Six: Unlikely Heroes
Breakthrough, Part Five: The Covid Fortress
Breakthrough, Part Four: Covid’s Long, Scary Tail
Create your
podcast in
minutes
It is Free
Mythology
Tiny Desk Concerts - Video
Matter of Opinion
Proof
Brought to you by...